DUBLIN--(BUSINESS WIRE)--The "Global Anticoagulants Market (2018-2022 Edition)" report has been added to ResearchAndMarkets.com's offering.
The report entitled Global Anticoagulants Market (2018-2022 Edition) provides an in-depth analysis of the global anticoagulants market with description of market size and growth. The analysis include market share by treatment, by segment, and by products.
The report also provides an analysis of injectable and oral anticoagulants available in the market. Details of Lovenox, Arixtra, Xarelto, Eliquis, Pradaxa and Savaysa has been provided in the report in terms of their global sales.
A brief analysis of the US anticoagulants market has also been provided in terms of value and sales of top four oral anticoagulant drugs in the region.
The global anticoagulants market has increased over the years and is expected to grow in the next four years i.e. 2018-2022, particularly due to development of novel oral anticoagulants (NOACs). The global anticoagulants market is supported by various growth drivers such as growing aging population, rising prevalence of coagulant disorders, increasing demand for NOACs, rising awareness about anticoagulants, etc. Yet, the market faces some challenges which are obstructing the growth of the market. Some of the challenges are stringent regulations from regulatory bodies, high cost of oral anticoagulants, major side-effects associated with the drugs.
Furthermore, the report also assesses the key opportunities available in the market and outline the market dynamics that are and will be accountable for growth of the industry. Growth of the global anticoagulants market has also been forecasted for the period 2018-2022, taking into consideration previous growth outlines, growth drivers and the existing and forthcoming trends.
Bayer, BMS/Pfizer, Boehringher Ingelheim and Daiichi Sankyo are some of the key players operating in the global anticoagulants market, whose company profiling has been done in the report. This segment summarizes business overview, financial overview and the business strategies of the companies.
Key Topics Covered:
1. Executive Summary
3. Global Market Analysis
4. Global Anticoagulants Product Analysis
5. Regional Analysis
6. Competitive Landscape
7. Company Profiles
- Boehringher Ingelheim
- Daiichi Sankyo
For more information about this report visit https://www.researchandmarkets.com/research/jtxfsm/global?w=4